Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Modern Molecular Taxonomy01:29

Modern Molecular Taxonomy

833
Advancements in molecular biology have revolutionized the identification and characterization of bacteria, with multiple methods leveraging DNA sequencing for enhanced precision. As sequencing technologies improve and costs decline, these approaches are increasingly used in clinical, environmental, and evolutionary studies.Multilocus Sequence Typing (MLST) examines several housekeeping genes, essential chromosomal genes encoding cellular functions, to distinguish strains. Approximately...
833
Applications of Molecular Taxonomy01:20

Applications of Molecular Taxonomy

705
Molecular taxonomy has revolutionized the understanding and classification of bacteria, providing precise insights into their diversity, evolutionary relationships, and ecological roles. By utilizing molecular techniques such as DNA sequencing and fingerprinting, researchers have made significant strides in various fields related to bacterial studies.Resolving Taxonomic AmbiguitiesMolecular taxonomy has been instrumental in distinguishing closely related bacterial species initially thought to...
705

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Non-uniform growth probability of Mycobacterium tuberculosis across inoculum densities partially restored by culture filtrate: Implications for supplemented growth assays.

Journal of microbiological methods·2026
Same author

Guanilated Quinolones with Dual Antitubercular and Anti-Inflammatory Activities.

ChemMedChem·2026
Same author

Beyond Inhibition: Sublethal Rifampicin-Induced Molecular Adaptations Confer Phenotypic Drug Tolerance in Mycobacteria.

ACS infectious diseases·2026
Same author

Integrating chemical, genetic, and feasibility assessments for anti-tubercular target validation.

EMBO molecular medicine·2026
Same author

Novel, Achiral 4‑Nitroimidazole Compounds with Potent Antitubercular Activity.

ACS omega·2026
Same author

Cobamide metabolism, regulation, and adaptation in <i>Mycobacterium tuberculosis</i>.

Journal of bacteriology·2025
Same journal

Advances in virtual screening.

Drug discovery today. Technologies·2024
Same journal

Integration of virtual and physical screening.

Drug discovery today. Technologies·2024
Same journal

A technical overview of supercritical fluid chromatography-mass spectrometry (SFC-MS) and its recent applications in pharmaceutical research and development.

Drug discovery today. Technologies·2021
Same journal

Mass spectrometry based approaches and strategies in bioanalysis for qualitative and quantitative analysis of pharmaceutically relevant molecules.

Drug discovery today. Technologies·2021
Same journal

Drug discovery from natural products using affinity selection-mass spectrometry.

Drug discovery today. Technologies·2021
Same journal

Editorial for the role(s) of MS in drug research and development.

Drug discovery today. Technologies·2021
See all related articles

Related Experiment Video

Updated: Apr 27, 2026

Identification of Mycobacterium Species by DNA Microarray Chip Method
06:27

Identification of Mycobacterium Species by DNA Microarray Chip Method

Published on: June 24, 2025

799

Mycobacterial genetics in target validation.

Digby F Warner1, Valerie Mizrahi1

  • 1MRC/NHLS/WITS Molecular Mycobacteriology Research Unit, School of Pathology of the University of the Witwatersrand and the National Health Laboratory Service, PO Box 1038, Johannesburg 2000, South Africa.

Drug Discovery Today. Technologies
|July 2, 2014
PubMed
Summary
This summary is machine-generated.

New anti-tuberculosis drugs are urgently needed due to widespread Mycobacterium tuberculosis infection and drug resistance. This review explores using mycobacterial genetics for validating new drug targets to combat tuberculosis.

More Related Videos

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray
07:35

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

Published on: April 25, 2014

12.2K
Matrix-based DNA Extraction for Targeted Next-Generation Sequencing on Decontaminated Sputum Samples
06:07

Matrix-based DNA Extraction for Targeted Next-Generation Sequencing on Decontaminated Sputum Samples

Published on: June 6, 2025

1.5K

Related Experiment Videos

Last Updated: Apr 27, 2026

Identification of Mycobacterium Species by DNA Microarray Chip Method
06:27

Identification of Mycobacterium Species by DNA Microarray Chip Method

Published on: June 24, 2025

799
Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray
07:35

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

Published on: April 25, 2014

12.2K
Matrix-based DNA Extraction for Targeted Next-Generation Sequencing on Decontaminated Sputum Samples
06:07

Matrix-based DNA Extraction for Targeted Next-Generation Sequencing on Decontaminated Sputum Samples

Published on: June 6, 2025

1.5K

Area of Science:

  • Microbiology
  • Genetics
  • Pharmacology

Background:

  • Tuberculosis (TB) remains a global health crisis, with one-third of the world infected by Mycobacterium tuberculosis.
  • No new first-line anti-TB drugs have been developed since 1970, highlighting a critical therapeutic gap.
  • The rise of multi-drug resistant strains and the HIV pandemic exacerbate the urgent need for novel TB treatments.

Purpose of the Study:

  • To review recent advances in mycobacterial genetics.
  • To highlight the application of these advances in identifying and validating novel drug targets for tuberculosis.
  • To underscore the potential of genetic approaches in developing new anti-TB agents.

Main Methods:

  • Review of current literature on mycobacterial genetics.
  • Analysis of genetic techniques for target identification and validation in Mycobacterium tuberculosis.
  • Discussion of how genetic insights can inform drug discovery pipelines.

Main Results:

  • Recent genetic advancements offer powerful tools for understanding Mycobacterium tuberculosis.
  • These tools enable more precise identification and validation of essential genes and pathways as drug targets.
  • Genetic approaches can accelerate the development of urgently needed anti-TB therapies.

Conclusions:

  • Mycobacterial genetics provides a promising avenue for TB drug discovery.
  • Target validation through genetic methods is crucial for developing effective new anti-TB drugs.
  • Integrating genetic insights is essential to overcome challenges posed by drug resistance and persistent infections.